ESC Premium Access

Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

Congress Presentation

About the speaker

Doctor Kristian Hellenkamp

University Medical Centre of Gottingen (UMG), Goettingen (Germany)
0 follower

6 more presentations in this session

Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events

Speaker: Doctor W. Chang (Tainan, TW)


Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)


A novel experimental in vivo model of acute pulmonary embolism

Speaker: Doctor J. Schultz (Aarhus, DK)


The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms

Speaker: Doctor E. Klok (Leiden, NL)


Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice

Speaker: Doctor C. Coleman (Storrs, US)


Access the full session

What is new in venous thromboembolism?

Speakers: Doctor K. Hellenkamp, Doctor W. Chang, Ms C. Sindet-Pedersen, Doctor J. Schultz, Doctor E. Klok...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by